Open Now
Contact Information
11390 East Via Linda Street Suite 103, Scottsdale, Arizona 85259, United States
Detailed Information
Medical X
-
Services:
- Smoking permitted in designated area
- Substance use disorder education
- Hepatitis education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Vaping permitted in designated area
- Telemedicine/telehealth therapy
- Relapse prevention
- Other contracted prescribing entity
- Lofexidine or Clonidine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Prescribes naltrexone
- Buprenorphine detoxification
- Detoxification
- Substance use treatment
- Cash or self-payment
- This facility administers/prescribes medication for alcohol use disorder
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- HIV testing
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Testing for Hepatitis B (HBV)
- TB screening
- STD testing
- Drug Enforcement Agency (DEA)
- SAMHSA certification for opioid treatment program (OTP)
- Female
- Male
- Adolescents
- Pregnant/postpartum women
- Complete medical history/physical exam
- Screening for mental disorders
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Interim services for clients
- Screening for substance use
- Outreach to persons in the community
- Screening for tobacco use
- Professional interventionist/educational consultant
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Buprenorphine (extended-release, injectable)
- Nicotine replacement
- Lofexidine
- Naltrexone (oral)
- Buprenorphine sub-dermal implant
- Acamprosate (CampralĀ®)
- Non-nicotine smoking/tobacco cessation
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Naltrexone (extended-release, injectable)
- Clonidine
- Medication for mental disorders
- Disulfiram
- Integrated primary care services
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Cocaine Detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Private for-profit organization
- Housing services
- Recovery coach
Facility Smoking Policy
Education and Counseling Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Vaping Policy
Treatment Approaches
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Opioid Treatment
Type of Care
Payment/Insurance/Funding Accepted
Type of Alcohol Use Disorder Treatment
Testing
License/Certification/Accreditation
Gender Accepted
Special Programs/Groups Offered
Assessment/Pre-treatment
Transitional Services
Opioid Medications used in Treatment
Pharmacotherapies
Ancillary Services
Detoxification (medical withdrawal) Services
Facility Operation (e.g., Private, Public)
Recovery Support Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm